Efficacy and safety of once‐daily inhaled ciclesonide in adults with mild to moderate asthma: A double‐blind, placebo‐controlled study*

Abstract

Once-daily administration of ciclesonide at doses of 100, 200 or 400 microg was shown to be effective in adult patients with mild to moderate asthma. Ciclesonide is considered to have favourable safety profiles and be well tolerated.